Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study.
Yung WK; Vredenburgh JJ; Cloughesy TF; Nghiemphu P; Klencke B; Gilbert MR; Reardon DA; Prados MD; Neuro-Oncology, 2010, vol. 12, issue 10, p 1061, ISSN 15235866. ISBN 15235866.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef